← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

RenaissanceRe Holdings Ltd. (RNR) 10-Year Financial Performance & Capital Metrics

RNR • • Insurance & Managed Care
Financial ServicesReinsuranceProperty & Casualty ReinsuranceGlobal Property Catastrophe Reinsurers
AboutRenaissanceRe Holdings Ltd. provides reinsurance and insurance products in the United States and internationally. The company operates through Property, and Casualty and Specialty segments. The Property segment writes property catastrophe excess of loss reinsurance and excess of loss retrocessional reinsurance to insure insurance and reinsurance companies against natural and man-made catastrophes, including hurricanes, earthquakes, typhoons, and tsunamis, as well as claims arising from other natural and man-made catastrophes comprising winter storms, freezes, floods, fires, windstorms, tornadoes, explosions, and acts of terrorism; and other property class of products, such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional U.S. multi-line reinsurance. The Casualty and Specialty segment writes various classes of products, such as directors and officers, medical malpractice, and professional indemnity; automobile and employer's liability, casualty clash, umbrella or excess casualty, workers' compensation, and general liability; financial and mortgage guaranty, political risk, surety, and trade credit; and accident and health, agriculture, aviation, cyber, energy, marine, satellite, and terrorism. The company distributes its products and services primarily through intermediaries. RenaissanceRe Holdings Ltd. was founded in 1993 and is headquartered in Pembroke, Bermuda.Show more
  • Revenue $11.65B +28.1%
  • Combined Ratio 73.9% +12.3%
  • Net Income $1.87B -27.0%
  • Return on Equity 11.3% -43.9%
  • Medical Cost Ratio 68.48% +14.3%
  • Operating Margin 26.1% -23.7%
  • Net Margin 16.06% -43.0%
  • ROA 3.75% -37.3%
  • Equity / Assets 34.61% +9.0%
  • Book Value per Share 341.88 +4.6%
  • Tangible BV/Share 328.16 +5.7%
  • Debt/Equity 0.11 -14.6%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Profitable underwriting: 73.9% combined ratio
  • ✓Strong 5Y profit CAGR of 20.1%
  • ✓Trading near 52-week high
  • ✓Trading at only 0.8x book value

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y25.17%
5Y22.76%
3Y30.3%
TTM-3.9%

Profit (Net Income) CAGR

10Y13.38%
5Y20.09%
3Y-
TTM-52.48%

EPS CAGR

10Y10.82%
5Y16.67%
3Y-
TTM-48.15%

ROCE

10Y Avg4.48%
5Y Avg3.84%
3Y Avg4.62%
Latest10.26%

Peer Comparison

Global Property Catastrophe Reinsurers
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
RNRRenaissanceRe Holdings Ltd.12.54B271.897.7228.13%14.31%9.13%33.22%0.11

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Revenue+1.49B1.73B2.1B2.06B4.18B5.16B5.27B5.05B9.09B11.65B
Revenue Growth %0.21%0.16%0.21%-0.02%1.03%0.23%0.02%-0.04%0.8%0.28%
Medical Costs & Claims+686.83M820.15M2.21B1.55B2.86B3.82B5.09B5.91B5.45B7.98B
Medical Cost Ratio %----------
Gross Profit+807.79M906.72M-112.67M503.46M1.32B1.33B174.46M-858.28M3.64B3.67B
Gross Margin %----------
Gross Profit Growth %-0.09%0.12%-1.12%5.47%1.62%0.01%-0.87%-5.92%5.24%0.01%
Operating Expenses+311.42M276.33M215.51M240.84M352M336.92M288.56M360.55M532.53M631.37M
OpEx / Revenue %----------
Depreciation & Amortization18.18M29.3M31.24M123K-58.96M16.65M-20.99M-26.95M-134.75M-76.08M
Combined Ratio %----------
Operating Income+496.38M630.39M-328.18M262.62M967.48M995.92M-114.11M-1.22B3.11B3.04B
Operating Margin %----------
Operating Income Growth %-0.28%0.27%-1.52%1.8%2.68%0.03%-1.11%-9.68%3.55%-0.02%
EBITDA+514.55M659.69M-296.94M262.74M908.52M1.01B-135.1M-1.25B2.98B2.96B
EBITDA Margin %----------
Interest Expense36.27M42.14M44.19M47.07M58.36M50.45M47.54M48.34M73.18M93.77M
Non-Operating Income-36.27M-42.14M-44.19M-47.07M-58.36M-50.45M-47.54M-48.34M-73.18M-47.09M
Pretax Income+496.38M630.39M-328.18M262.62M967.48M995.92M-114.11M-1.22B3.11B2.99B
Pretax Margin %----------
Income Tax+-45.87M340K26.49M-6.3M17.21M2.86M-10.67M-59.02M-510.07M32.63M
Effective Tax Rate %----------
Net Income+431.19M502.96M-222.39M227.36M748.8M762.4M-40.16M-1.06B2.56B1.87B
Net Margin %----------
Net Income Growth %-0.19%0.17%-1.44%2.02%2.29%0.02%-1.05%-25.43%3.41%-0.27%
EPS (Diluted)+9.2811.43-5.585.7216.2915.31-1.57-25.5052.2735.21
EPS Growth %-0.26%0.23%-1.49%2.03%1.85%-0.06%-1.1%-15.24%3.05%-0.33%
EPS (Basic)9.3611.50-5.585.7216.3215.34-1.57-25.5052.4035.31
Diluted Shares Outstanding43.53M41.56M39.85M39.76M43.17M47.18M47.17M43.04M47.61M51.34M

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Assets+11.56B12.35B15.23B18.68B26.33B30.82B33.96B36.55B49.01B50.71B
Asset Growth %0.41%0.07%0.23%0.23%0.41%0.17%0.1%0.08%0.34%0.03%
Total Investment Assets+9B9.32B9.5B11.89B21.9B25.26B24.75B25.7B32.31B32.64B
Long-Term Investments8.97B9.29B9.49B11.86B17.33B20.26B19.45B21.03B27.7B28.11B
Short-Term Investments1.23B1.37B991.86M2.59B4.57B4.99B5.3B4.67B4.6B4.53B
Total Current Assets+10.28B2.78B3.66B7.86B11.41B13.12B15.59B587.13M7.41B1.68B
Cash & Equivalents506.88M421.16M1.36B1.11B1.38B1.74B1.86B1.19B1.88B1.68B
Receivables1000K0001000K1000K1000K1000K1000K1000K
Other Current Assets2.76B0008.51B010.89B-441.33M-13.25B-16.39B
Goodwill & Intangibles+265.15M251.19M243.15M237.42M262.23M249.64M243.5M237.83M775.35M704.13M
Goodwill197.59M197.59M197.59M197.59M210.68M211.01M206.32M206.29M300.54M300.51M
Intangible Assets67.56M53.6M45.55M39.83M51.54M38.63M37.18M31.53M474.81M403.63M
PP&E (Net)0-94.4M-73.42M11.98B62.6M47.8M50.9M83.7M89.5M0
Other Assets-7.96B30.6M1.84B-12.1B-222.65M-1.2B-167.91M-16.32B-89.5M-27.41B
Total Liabilities5.78B6.31B9.54B11.58B17.29B19.87B23.78B26.69B33.45B33.16B
Total Debt+966.08M948.66M989.62M991.13M1.38B1.14B1.17B1.17B1.96B1.89B
Net Debt459.19M527.51M-371.97M-116.8M5.04M-600.55M-690.67M-23.9M81.14M210.09M
Long-Term Debt966.08M948.66M989.62M991.13M1.38B1.14B1.14B1.14B1.88B1.44B
Short-Term Debt00000030M30M75M449.81M
Total Current Liabilities+5.86B6.54B9.85B1.9B18.97B3.49B3.89B111.84M020.23B
Accounts Payable523.97M673.98M989.09M1.9B2.83B3.49B3.86B3.93B3.19B2.8B
Deferred Revenue0-500M002.33B000661.61M0
Other Current Liabilities-915.35M-479.7M-1.2B-2.28B13.59B-1.13B-1.17B-4.34B-4.58B16.82B
Deferred Taxes01000K1000K1000K1000K01000K1000K00
Other Liabilities-5.58M00910.93M000153.67M31.57B449.81M
Total Equity+5.78B6.04B5.69B7.1B9.04B10.95B10.18B9.86B15.56B17.55B
Equity Growth %0.16%0.05%-0.06%0.25%0.27%0.21%-0.07%-0.03%0.58%0.13%
Shareholders Equity4.73B4.87B4.39B5.05B5.97B7.56B6.62B5.33B9.45B10.57B
Minority Interest1.05B1.18B1.3B2.05B3.07B3.39B3.55B4.54B6.1B6.98B
Retained Earnings3.78B4.21B3.91B4.06B4.71B5.37B5.23B4.07B6.52B8.28B
Common Stock43.7M41.19M40.02M42.21M44.15M50.81M44.45M43.72M52.69M50.18M
Accumulated OCI2.11M1.13M224K-1.43M-1.94M-12.64M-10.91M-15.46M-14.21M-14.76M
Return on Equity (ROE)0.08%0.09%-0.04%0.04%0.09%0.08%-0%-0.11%0.2%0.11%
Return on Assets (ROA)0.04%0.04%-0.02%0.01%0.03%0.03%-0%-0.03%0.06%0.04%
Equity / Assets----------
Debt / Equity0.17x0.16x0.17x0.14x0.15x0.10x0.11x0.12x0.13x0.11x
Book Value per Share132.75145.39142.72178.51209.44232.07215.78229.10326.75341.88
Tangible BV per Share----------

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+414.74M469.83M1.05B1.22B2.14B1.99B1.23B1.6B1.91B4.16B
Operating CF Growth %-0.37%0.13%1.23%0.17%0.75%-0.07%-0.38%0.3%0.19%1.18%
Operating CF / Revenue %----------
Net Income542.24M630.05M-354.67M268.92M950.27M993.06M-103.44M-1.16B3.62B2.96B
Depreciation & Amortization18.18M29.3M31.24M123K-58.96M16.65M-20.99M-26.95M-134.75M258.46M
Stock-Based Compensation38.3M47.4M37.2M35.7M043.7M40M45.2M00
Deferred Taxes00000-43.7M-40M-45.2M00
Other Non-Cash Items72.81M-147.37M-154.26M179.61M-414.87M-788.83M219.1M1.65B-490.44M-20.4M
Working Capital Changes-218.49M-42.16M1.52B773.05M1.66B1.77B1.14B1.14B-1.08B966.24M
Cash from Investing+-339.04M-164.53M-142.43M-2.54B-2.99B-2.3B-816.3M-3.02B-3.82B-3.06B
Capital Expenditures000002.3B816.3M-481.3M00
Acquisitions-688.3M-2.99M260.48M-13.01M-267.67M142.3M-15.49M1.48M-1.89B-15.99M
Purchase of Investments-9.68B-8.35B-10.11B-13.93B-20.03B-17.63B-16.55B-25.74B-25.03B-59.48B
Sale/Maturity of Investments1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Investing4.5M400K-122.43M2.5M-4.11M-2.3B-816.3M481.3M-539.06M57.34M
Cash from Financing+-83.67M-386.39M28.86M1.07B1.12B665.21M-302.46M725.34M2.59B-1.29B
Dividends Paid-76.35M-73.96M-73.75M-82.93M-96.12M-99.41M-100.72M-100.07M-110.49M-116.22M
Share Repurchases-259.87M-309.43M-188.59M00-187.62M-1.3B-166.66M0-666.92M
Stock Issued000250M01.1B488.65M01.35B0
Debt Issuance (Net)1000K01000K01000K-1000K1000K01000K-1000K
Other Financing-203.28M-2.99M245.34M657.82M819.83M106.74M582.11M992.08M561.94M-429.37M
Net Change in Cash+-18.7M-85.73M940.43M-253.67M271.15M357.75M122.21M-664.68M683.18M-200.91M
Exchange Rate Effect-1000K-1000K1000K-1000K1000K1000K1000K1000K1000K-1000K
Cash at Beginning525.58M506.88M421.16M1.36B1.11B1.38B1.74B1.86B1.19B1.88B
Cash at End506.88M421.16M1.36B1.11B1.38B1.74B1.86B1.19B1.88B1.68B
Free Cash Flow+414.74M469.83M1.05B1.22B2.14B4.3B2.05B1.12B1.91B4.16B
FCF Growth %-0.37%0.13%1.23%0.17%0.75%1.01%-0.52%-0.45%0.7%1.18%
FCF Margin %----------
FCF per Share9.5311.3126.2430.7349.591.0943.4826.0840.1581.12

Key Ratios

Metric2015201620172018201920202021202220232024
Combined Ratio66.79%63.5%115.66%87.23%76.85%80.68%102.17%124.14%65.79%73.9%
Medical Cost Ratio45.95%47.49%105.38%75.52%68.42%74.15%96.69%117%59.93%68.48%
Return on Equity (ROE)8%8.51%-3.79%3.56%9.28%7.63%-0.38%-10.59%20.15%11.3%
Return on Assets (ROA)4.36%4.21%-1.61%1.34%3.33%2.67%-0.12%-3.01%5.99%3.75%
Equity / Assets49.98%48.92%37.36%38%34.34%35.52%29.97%26.98%31.74%34.61%
Book Value / Share132.75145.39142.72178.51209.44232.07215.78229.1326.75341.88
Debt / Equity0.17x0.16x0.17x0.14x0.15x0.10x0.11x0.12x0.13x0.11x
Revenue Growth21.12%15.54%21.36%-1.87%103.2%23.37%2.14%-4.11%80.05%28.13%

Revenue by Segment

2015201620172018201920202021202220232024
Casualty and Specialty-682.34M786.5M925.3M1.71B2.02B2.59B3.56B4.38B6.25B
Casualty and Specialty Growth--15.27%17.65%84.90%17.85%28.25%37.82%22.91%42.58%
Property-720.95M931.07M1.05B1.63B1.94B2.61B2.77B3.09B3.85B
Property Growth--29.14%12.86%54.88%18.97%34.71%6.21%11.57%24.57%
Others-48K---------
Others Growth----------
Catastrophe Reinsurance622.71M---------
Catastrophe Reinsurance Growth----------
Specialty Reinsurance548.81M---------
Specialty Reinsurance Growth----------
Lloyds229.07M---------
Lloyds Growth----------

Frequently Asked Questions

Valuation & Price

RenaissanceRe Holdings Ltd. (RNR) has a price-to-earnings (P/E) ratio of 7.7x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

RenaissanceRe Holdings Ltd. (RNR) grew revenue by 28.1% over the past year. This is strong growth.

Yes, RenaissanceRe Holdings Ltd. (RNR) is profitable, generating $1.73B in net income for fiscal year 2024 (16.1% net margin).

Dividend & Returns

Yes, RenaissanceRe Holdings Ltd. (RNR) pays a dividend with a yield of 0.58%. This makes it attractive for income-focused investors.

RenaissanceRe Holdings Ltd. (RNR) has a return on equity (ROE) of 11.3%. This is reasonable for most industries.

Industry Metrics

RenaissanceRe Holdings Ltd. (RNR) has a combined ratio of 73.9%. A ratio below 100% indicates underwriting profitability.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.